1

Jubilant Pharmova

#4379

Rank

$2.25B

Marketcap

IN India

Country

Jubilant Pharmova
Leadership team

Mr. Hari Shanker Bhartia B.E., B.Tech (Co-Chairman & MD)

Mr. Arun Kumar Sharma B.Sc., BSc., C.A., CA (Head-Group Treasury & CFO)

Mr. Arvind Chokhany (Group CFO & Whole-Time Director)

Products/ Services
Health Care, Manufacturing, Pharmaceutical
Number of Employees
1,000 - 20,000
Headquarters
Singapore, Central Region, Singapore
Established
1978
Net Income
20M - 100M
Revenue
500M - 1B
Traded as
JUBLPHARMA.NS
Overview
Location
Summary
Jubilant Pharmova Limited operates as an integrated pharmaceutical and life sciences company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the manufacturing and supply of allergy therapy products, contract manufacturing of sterile injectables and non-sterile products, active pharmaceutical ingredients, and solid dosage formulations, as well as sale of radiopharmaceuticals through a network of 48 radio pharmacies in the United States. The Contract Research & Development Services segment provides collaborative research services to pharmaceutical innovators. The Proprietary Novel Drugs segment develops therapies in the areas of oncology and auto-immune disorders. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. Jubilant Pharmova Limited was incorporated in 1978 and is based in Noida, India.
History

Brothers Shyam Sundar Bhartia and Hari Bhartia founded Vam Organics Limited on 21 June 1978. The name was the abbreviation of the product the company manufactured, vinyl acetate monomer . The business was seeded with funds obtained from their father Mohan Lal Bhartia, who was a steel wire and Rolex watch trader in Kolkata. Vam Organics gained opportunities to carry out higher-value work for drug and chemical industries following economic liberalisation in India in the 1990s. The company was renamed Jubilant Organosys in 2001, which began the use of the name "Jubilant" for the group.On the recommendation of a friend who owned foreign pizza licences, the Bhartias entered into a master franchise partnership with Domino's Pizza in 1996 and established Dominos Pizza India Private Limited. The company changed its name to Jubilant FoodWorks in 2009.The Jubilant Bhartia Group had revenues of over $3 billion in 2012.

Mission
Our Promise Caring, Sharing, Growing We will, with utmost care for the environment and society, continue to enhance value for our customers by providing innovative products and economically efficient solutions; and for our stakeholders through growth, cost effectiveness and wise investment of resources
Vision
To Acquire and maintain global leadership posion in chosen areas of businesses to continuously create new opportunities for growth in our strategic businesses to be among the top 10 most admired companies to work for to continuously achieve a return on invested capital of at least 10 points higher than the cost of capital
Key Team

Mr. Devarajan Jagannathan A.C.S., B.Com. (Sr. VP of Indirect Taxation)

Mr. Umesh Mehta B.Sc., PGLSCM (Chief Information Officer)

Mr. K.V.S Satish Kumar (Chief Sustainability Officer)

Mr. Sanjay Gupta A.C.M.A., B.Com., L.L.B. (Exec. VP & Head of Legal)

Mr. Shyam Pattabiraman (CFO of Therapeutics Bus.)

Ms. Rohini Seth (Chief HR Officer)

Mr. Praveen Kumar Gupta B.Com, B.Com., Ca, Cs, F.C.A. (Exec. VP & Head of Direct Taxation)

Recognition and Awards
Jubilant Pharmova has won numerous awards and recognition in India, including the National Quality Excellence Award in 2019 for its contribution to the healthcare industry.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Jubilant Pharmova
Leadership team

Mr. Hari Shanker Bhartia B.E., B.Tech (Co-Chairman & MD)

Mr. Arun Kumar Sharma B.Sc., BSc., C.A., CA (Head-Group Treasury & CFO)

Mr. Arvind Chokhany (Group CFO & Whole-Time Director)

Products/ Services
Health Care, Manufacturing, Pharmaceutical
Number of Employees
1,000 - 20,000
Headquarters
Singapore, Central Region, Singapore
Established
1978
Net Income
20M - 100M
Revenue
500M - 1B
Traded as
JUBLPHARMA.NS